Geficad Tablet

Introduction to Geficad Tablet

The Geficad Tablet is a medication primarily used to treat a specific type of lung cancer known as non-small cell lung cancer (NSCLC). It is particularly effective for patients with certain gene mutations called EGFR mutations. This tablet is often prescribed to patients who have not undergone prior chemotherapy.

Composition of Geficad Tablet

The active ingredient in Geficad Tablet is Gefitinib, which is an EGFR tyrosine kinase inhibitor. This means it works by blocking signals that promote cancer cell growth, specifically targeting mutated EGFR receptors.

Uses of Geficad Tablet

• Treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC).
• Specifically targets cancer with EGFR mutations.
• Prescribed for patients who have not received prior chemotherapy.

Side effects of Geficad Tablet

Common side effects:

• Diarrhea
• Skin rash
• Nausea
• Vomiting
• Loss of appetite

Serious side effects:

• Liver toxicity
• Lung inflammation
• Severe diarrhea leading to dehydration

Precautions of Geficad Tablet

Geficad Tablet should not be taken by individuals without EGFR mutations, pregnant or breastfeeding women, or those with severe liver or kidney disease. It is also contraindicated for patients with a history of interstitial lung disease or those allergic to Gefitinib or any of its ingredients.

How to Take Geficad Tablet

• Take one tablet orally, once daily.
• It is best to take it at the same time each day.
• Follow your doctor's instructions regarding dosage and duration.

Conclusion of Geficad Tablet

The Geficad Tablet is a targeted therapy for non-small cell lung cancer with EGFR mutations. While it offers significant benefits, it is important to be aware of its side effects and take necessary precautions. Always consult with your healthcare provider for personalized advice and treatment plans.